Serina Therapeutics (SER) FCF Margin (2018 - 2025)
Serina Therapeutics (SER) posted FCF Margin of 2920.0% for Q2 2025, down 108.9% sequentially from 32814.29% in Q4 2024, and up 1278392.0% YoY from N/an in Q2 2024.
Serina Therapeutics (SER) FCF Margin (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported FCF Margin for 8 years, with the latest figure at 2920.0% in Q2 2025.
- Quarterly FCF Margin rose 1278392.0% year-over-year to 2920.0% in Q2 2025, while the trailing twelve-month figure through Dec 2025 was 13856.92% (up 1678415.0% YoY) and the FY2025 annual result came in at 13856.92%, up 1678415.0% from the prior year.
- FCF Margin declined to 2920.0% in Q2 2025 per SER's latest filing, from 32814.29% in the prior quarter.
- Over five years, FCF Margin peaked at 32814.29% in Q4 2024 and troughed at 32720.0% in Q1 2022.
- A 5-year average of 8993.41% and a median of 7475.0% in 2021 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 3281263 bps in 2024, down 2945667 bps in 2024.
- Over 5 years, FCF Margin stood at 1085.62% in 2021, then slumped by 1421 bps to 16512.5% in 2022, then jumped by 100 bps to 1.65% in 2023, then jumped by 1986129 bps to 32814.29% in 2024, then sank by 109 bps to 2920.0% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 2920.0%, 32814.29%, and 21178.57% for Q2 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,920.00% |
| Dec 31, 2024 | 32,814.29% |
| Sep 30, 2024 | -21,178.57% |
| Jun 30, 2024 | -15,703.92% |
| Mar 31, 2024 | -31,820.00% |
| Dec 31, 2023 | 1.65% |
| Sep 30, 2023 | -3,941.38% |
| Jun 30, 2023 | -12,342.86% |
| Mar 31, 2023 | -2,363.33% |
| Dec 31, 2022 | -16,512.50% |
| Sep 30, 2022 | -13,733.33% |
| Jun 30, 2022 | -14,550.00% |
| Mar 31, 2022 | -32,720.00% |
| Dec 31, 2021 | -1,085.63% |
| Sep 30, 2021 | -7,475.00% |
| Jun 30, 2021 | -4,821.62% |
| Mar 31, 2021 | -4,535.71% |
| Dec 31, 2020 | -1,146.20% |
| Sep 30, 2020 | -2,633.33% |
| Jun 30, 2020 | -5,182.22% |